Organization Overview
Alternative names
acetaminophen (tylenol) (3 trials)
aliskiren (tekturna) (2 trials)
autologous microbiome (1 trial)
bisacodyl (Halflytely) (1 trial)
capecitabine (xeloda) (8 trials)
cisplatin (platinol) (11 trials)
cobicistat (stribild) (1 trial)
corifollitropin alfa (1 trial)
desmopressin (ddavp) (1 trial)
dolutegravir (tivicay) (4 trials)
emtricitabine (emtriva) (1 trial)
evolocumab (repatha) (2 trials)
follitropin beta (Follistim) (1 trial)
gemcitabine (gemzar) (7 trials)
insulin glargine (toujeo) (1 trial)
insulin human (humulin) (1 trial)
meperidine (demerol) (1 trial)
oxycodone (oxycontin) (2 trials)
pioglitazone (actos) (1 trial)
prednisone (meticorten) (3 trials)
propofol (diprivan) (4 trials)
amino acids (Freamine) (1 trial)
atazanavir (reyataz) (2 trials)
atezolizumab (Tecentriq) (2 trials)
bevacizumab (avastin) (2 trials)
carboplatin (paraplatin) (7 trials)
cyclophosphamide (cytoxan) (10 trials)
docetaxel (taxotere) (3 trials)
drotrecogin alfa, activated (Xigris) (1 trial)
epirubicin (ellence) (7 trials)
esomeprazole (nexium) (1 trial)
fenoldopam (corlopam) (1 trial)
fluorouracil (efudex) (4 trials)
glatiramer acetate (copaxone) (1 trial)
hsvtk retrovirally-transduced donor t lymphocytes (2 trials)
hydrochlorothiazide (esidrix) (1 trial)
immune globulin (human) (Gamastan) (2 trials)
ketorolac (acuvail) (2 trials)
lidocaine (xylocaine) (1 trial)
lopinavir (Kaletra) (2 trials)
metolazone (zaroxolyn) (1 trial)
oxaliplatin (eloxatin) (2 trials)
pertuzumab (perjeta) (2 trials)
pirfenidone (esbriet) (1 trial)
ada-transduced cd34+ cells (1 trial)
aldesleukin (Proleukin) (2 trials)
allogeneic bone marrow (1 trial)
allogeneic pancreatic islet cells (3 trials)
antithrombin iii (human) (thrombate iii) (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (3 trials)
atorvastatin (lipitor) (1 trial)
autologous hematopoietic stem cells genetically modified with globe lentiviral vector encoding for the human beta-globin gene (1 trial)
autologous mesenchymal stem cells (3 trials)
autologous mononuclear stem cell (2 trials)
bendamustine (treanda) (1 trial)
bone marrow derived mesenchymal stem cells (1 trial)
bortezomib (velcade) (1 trial)
cenegermin-bkbj (oxervate) (1 trial)
coagulation factor viia (recombinant) (NovoSevenRT) (1 trial)
colchicine (colbenemid) (1 trial)
cytarabine (cytosar-u) (5 trials)
daratumumab (darzalex) (1 trial)
defibrotide (defitelio) (1 trial)
doxycycline (vibramycin) (1 trial)
eltrombopag (promacta) (1 trial)
etoposide (vepesid) (3 trials)
Filgrastim (neupogen) (2 trials)
fludarabine (fludara) (4 trials)
frozen autologous cd34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector idua lv, encoding for the α-l-iduronidase cdna (1 trial)
fulvestrant (faslodex) (1 trial)
hydroxyurea (hydrea) (1 trial)
ibrutinib (imbruvica) (3 trials)
interferon beta-1a (Avonex) (1 trial)
lenalidomide (revlimid) (1 trial)
lutetium dotatate lu-177 (Lutathera) (1 trial)
methylene blue (proveblue) (1 trial)
methylprednisolone (medrol) (2 trials)
mitomycin (mutamycin) (2 trials)
mycophenolate (CellCept) (3 trials)
obinutuzumab (gazyva) (1 trial)
ofatumumab (arzerra) (1 trial)
ondansetron (zofran) (2 trials)
oxytocin (syntocinon) (1 trial)
palbociclib (ibrance) (1 trial)
pembrolizumab (keytruda) (2 trials)
pentostatin (nipent) (1 trial)
plerixafor (mozobil) (1 trial)
rituximab (rituxan) (10 trials)
romiplostim (nplate) (1 trial)
rosuvastatin (crestor) (1 trial)
sargramostim (leukine) (2 trials)
tirzepatide (Mounjaro) (1 trial)
tocilizumab (actemra) (1 trial)
trabectedin (yondelis) (3 trials)
triamcinolone (kenalog) (1 trial)
vemurafenib (zelboraf) (1 trial)
vinblastine (velban) (1 trial)
vincristine (oncovin) (2 trials)
Abdominal Pain (Phase 3)
Acute Disease (Phase 3)
Acute Kidney Injury (Phase 3)
Adenocarcinoma (Phase 4)
Amyotrophic Lateral Sclerosis (Phase 3)
Aneurysm (Phase 4)
Antithrombin III Deficiency (Phase 2)
Aortic Aneurysm (Phase 4)
Aortic Aneurysm, Thoracic (Phase 4)
Arrhythmias, Cardiac (Phase 3)
Arthritis (Phase 4)
Arthritis, Rheumatoid (Phase 4)
Atherosclerosis (Phase 3)
Atypical Hemolytic Uremic Syndrome (Phase 2)
Autism Spectrum Disorder (Phase 4)
Autistic Disorder (Phase 4)
Azotemia (Phase 2)
beta-Thalassemia (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Blood Loss, Surgical (Phase 4)
Blood Platelet Disorders (Phase 2)
Breast Neoplasms (Phase 3)
Bronchiolitis (Phase 4)
Burkitt Lymphoma (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Ductal, Breast (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Cardiac Output, Low (Phase 4)
Cardiomyopathies (Phase 2)
Cardiomyopathy, Hypertrophic (Phase 2)
Cardiovascular Diseases (Phase 3)
Carotid Stenosis (Phase 3)
Central Nervous System Neoplasms (Phase 2)
Cerebral Hemorrhage (Phase 2)
Chronic Pain (Phase 4)
Colorectal Neoplasms (Phase 2)
Communicable Diseases (Phase 4)
Constipation (Phase 2)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Coronary Restenosis (Phase 2)
Critical Illness (Phase 4)
Depression (Phase 4)
Depressive Disorder (Phase 4)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 3)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Nephropathies (Phase 2)
Edema (Phase 2)
Erdheim-Chester Disease (Phase 2)
Erectile Dysfunction (Phase 3)
Essential Hypertension (Phase 2)
Genomic Instability (Phase 2)
Glucose Intolerance (Phase 3)
Graft vs Host Disease (Phase 2)
Granulomatous Disease, Chronic (Phase 2)
Heart Diseases (Phase 4)
Heart Failure (Phase 3)
Hematologic Neoplasms (Phase 2)
Hemolysis (Phase 2)
Hemolytic-Uremic Syndrome (Phase 2)
Hemorrhage (Phase 4)
Hepatitis (Phase 3)
Hepatitis A (Phase 3)
Hepatitis C (Phase 3)
Hepatitis, Chronic (Phase 3)
HIV Infections (Phase 4)
HIV Seropositivity (Phase 2)
Hypercholesterolemia (Phase 4)
Hypertension (Phase 4)
Hypertrophy (Phase 2)
Hypogonadism (Phase 3)
Immunologic Deficiency Syndromes (Phase 2)
Infections (Phase 4)
Infertility (Phase 4)
Inflammation (Phase 2)
Insulin Resistance (Phase 3)
Ischemia (Phase 4)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 4)
Leiomyosarcoma (Phase 2)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Liposarcoma (Phase 2)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Macular Degeneration (Phase 3)
Macular Edema (Phase 2)
Melanoma (Phase 2)
Meningioma (Phase 2)
Metabolic Syndrome (Phase 3)
Migraine Disorders (Phase 4)
Motor Neuron Disease (Phase 3)
Mucopolysaccharidoses (Phase 2)
Mucopolysaccharidosis I (Phase 2)
Multiple Myeloma (Phase 2)
Multiple Sclerosis (Phase 3)
Multiple Sclerosis, Relapsing-Remitting (Phase 3)
Muscle Spasticity (Phase 3)
Mycoses (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Myocardial Ischemia (Phase 4)
Necrosis (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Nephrosis (Phase 2)
Nephrotic Syndrome (Phase 2)
Nervous System Neoplasms (Phase 2)
Neuroendocrine Tumors (Phase 2)
Osteoarthritis (Phase 4)
Osteoarthritis, Knee (Phase 3)
Ovarian Neoplasms (Phase 2)
Pain, Procedural (Phase 3)
Pancreatic Neoplasms (Phase 3)
Paresis (Phase 2)
Parkinson Disease (Phase 4)
Peripheral Arterial Disease (Phase 4)
Peripheral Vascular Diseases (Phase 4)
Pneumonia (Phase 2)
Pneumonia, Viral (Phase 2)
Polyradiculoneuropathy (Phase 3)
Postoperative Hemorrhage (Phase 4)
Preleukemia (Phase 2)
Prostatic Neoplasms (Phase 2)
Renal Insufficiency (Phase 3)
Renal Insufficiency, Chronic (Phase 4)
Respiratory Distress Syndrome (Phase 2)
Respiratory Insufficiency (Phase 2)
Retinitis (Phase 2)
Retinitis Pigmentosa (Phase 2)
Schizophrenia (Phase 2)
Sclerosis (Phase 3)
Sepsis (Phase 3)
Severe Combined Immunodeficiency (Phase 2)
Shock, Septic (Phase 3)
Shoulder Pain (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Stomach Neoplasms (Phase 3)
Suicide (Phase 2)
Syndrome (Phase 3)
Thalassemia (Phase 2)
Thrombocytopenia (Phase 2)
Thromboembolism (Phase 3)
Toxemia (Phase 3)
Urinary Bladder Neoplasms (Phase 2)
Vascular Diseases (Phase 4)
Venous Thromboembolism (Phase 3)
Viremia (Phase 2)
Virus Diseases (Phase 2)
Vision, Low (Phase 3)